Coronavirus Q&A: Covington's Life Sciences Chair

In this edition of Coronavirus Q&A, one of Covington & Burling LLP's top life sciences lawyers discusses strengths and weaknesses of the U.S. Food and Drug Administration's response to COVID-19 and...

Already a subscriber? Click here to view full article